entity

TREM2 R47H variant

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about TREM2 R47H variant: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

22Connections
3Hypotheses
5Analyses
18Outgoing
4Incoming
5Experiments
7Debates

No AI portrait yet

Outgoing (18)

TargetRelationTypeStr
benchmark_ot_ad_answer_key:TREM2 R47H VARIANTdata_indataset_row0.00
Alzheimer's Diseaserisk_factor_fordisease0.90
microglial responses to amyloidregulatesprocess0.90
microglial responses to amyloidmodulatesprocess0.90
DAM transitioninhibitsprocess0.90

Incoming (4)

SourceRelationTypeStr
benchmark_ot_ad_answer_key:TREM2 R47H VARIANTdata_indataset_row0.00
37591465increases risk ofpaper0.90
29859094confers increased risk forpaper0.90
29859094confers viapaper0.90

Targeting Hypotheses (3)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
TREM2 R47H Variant-Driven Metabolic Dysfunction as the Prima 0.862 neurodegeneration Variant Annotation and Prioritization of
TREM2 R47H variant synergizes with APOE4 to collapse microgl 0.681 neuroscience APOE4-driven lipid metabolism dysregulat
TREM2 R47H Variant Correction — AAV-Mediated Rescue of Commo 0.631 Alzheimer's disease TREM2 agonism vs antagonism in DAM micro

Mentioning Analyses (5)

Scientific analyses that reference this entity

test debate

neurodegeneration | 2026-04-15 | 0 hypotheses

What are the optimal timing windows for TREM2 inhibition vs activation in Alzhei

neurodegeneration | 2026-04-11 | 0 hypotheses

What are the optimal temporal windows for TREM2 inhibition vs activation in Alzh

neurodegeneration | 2026-04-11 | 0 hypotheses

Synaptic pruning by microglia in neurodegeneration

neurodegeneration | 2026-04-02 | 7 hypotheses Top: 0.720

TREM2 agonism vs antagonism in DAM microglia

neurodegeneration | 2026-04-01 | 6 hypotheses Top: 0.886

Experiments (5)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
NAD depletion effects on monocyte/macrophage differentiation exploratory Inflammatory bowel disease 0.900 0.00 Primary mouse and human monocy proposed N/A
FK866 treatment in DSS-induced colitis mouse model validation Inflammatory bowel disease (co 0.900 0.00 DSS-induced colitis mice proposed N/A
FK866 in azoxymethane/DSS colitis-associated cancer model validation Colitis-associated cancer 0.850 0.00 AOM/DSS-treated mice proposed N/A
FK866 mechanism validation in Rag1-/- mice validation Inflammatory bowel disease 0.850 0.00 Rag1-/- mice with DSS-induced proposed N/A
CHI3L1 variant association with AD progression in human patients exploratory Alzheimer's disease 0.850 0.00 human patients proposed N/A

Related Papers (17)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
The gain-of-function TREM2-T96K mutation increases risk for Alzheimer's disease [PMID:41109213] Pilat DJ, Le H, Prokopenko D, Lin CJ, Ei Neuron 2026 0
Role of TREM2 in neuroinflammation. [PMID:41213496] Abdulkhaliq AA, Alasiri G, Almoghrabi Y, Exp Neurol 2026 0
Synergistic potential of TREM2 agonists and exercise training in Alzheimer's dis [PMID:41494649] Zhang J, St Pierre Schneider B, Muguerza Am J Physiol Endocrinol Metab 2026 0
Armored macrophage-targeted CAR-T cells reset and reprogram the tumor microenvir [PMID:41576929] Mateus-Tique J, Lakshmi A, Singh B, Iyer Cancer Cell 2026 0
Peripheral cancer attenuates amyloid pathology in Alzheimer's disease via cystat [PMID:41576952] Li X, Tang X, Zeng J, Duan L, Hou Z et a Cell 2026 0
TREM2 expression level is critical for microglial state, metabolic capacity and [PMID:41580393] Feiten AF, Dahm K, Schlepckow K, van Len Nat Commun 2026 0
Large-scale single-cell analysis and in silico perturbation reveal dynamic evolu [PMID:41617928] Xia P, Shuang S, Fu D, Liu L, Yang D et NPJ Precis Oncol 2026 0
Dissecting genetic and immune drivers of heterogeneous responses to neoadjuvant [PMID:41720086] Zhao Q, Huang R, Wang C, Hu J, Nie R et Cancer Cell 2026 0
TREM2 in neurodegeneration and diseases. [PMID:41792456] ["Abdulkhaliq A", "Alasiri G", "Kim B", Molecular psychiatry 2026 0
Alzheimer's Disease as a Disorder of Neuroimmune Dysregulation. [PMID:41745721] Aranda-Abreu GE, Rojas-Durán F, Hernánde Neurology international 2026 0
Molecular mechanism of Alzheimer's disease using integrated multi-omics. [PMID:41907842] Alhusaini M, Mussa BM, Ilce BY, Alhaj H, Frontiers in aging neuroscienc 2026 0
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] ["Chen Kai", "Li Fuyao", "Zhang Shuwen", Journal of neuroinflammation 2025 0
Viral and non-viral cellular therapies for neurodegeneration. [PMID:41585268] ["Srivastav Jyotsna", "Sharma Sachin"] Frontiers in medicine 2025 0
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] ["Chen Kai", "Li Fuyao", "Zhang Shuwen", Journal of neuroinflammation 2025 0
Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] Marogianni C, Sokratous M, Dardiotis E, International journal of molec 2020 0
Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] Marogianni C, Sokratous M, Dardiotis E, International journal of molec 2020 0
Multiple Sclerosis Pathology. [PMID:29358320] Lassmann H Cold Spring Harbor perspective 2018 0

Debates (7)

Multi-agent debates referencing this entity

Hypothesis debate: PLCG2 Allosteric Modulation as a Precision Therapeutic for TR

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: PLCG2 Allosteric Modulation as a Precision Therapeutic for TR

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

What is the role of microglial synaptic pruning in Alzheimer's disease and other

closed · Rounds: 4 · Score: 0.68 · 2026-04-22

The debate proposed biphasic TREM2 modulation but couldn't define when to switch

closed · Rounds: 4 · Score: 0.30 · 2026-04-21

The debate proposed temporal TREM2 modulation but couldn't define when to switch

closed · Rounds: 4 · Score: 0.30 · 2026-04-21

test debate [TARGET_ARTIFACT type=experiment id=exp-123]

closed · Rounds: 4 · Score: 0.95 · 2026-04-16

The disease-associated microglia (DAM) phenotype involves TREM2 upregulation, bu

closed · Rounds: 4 · Score: 0.57 · 2026-04-01

Related Research

Hypotheses and analyses mentioning TREM2 R47H variant in their description or question text

No additional research found